Advancing human health through genetics
We identify the metabolic constraints people inherit, and the nutritional approaches that address them.
Mission, vision and promise
-
Mission
To enable people to take action on DNA-driven health concerns through genetic testing and precision nutrition.
-
Vision
To transform the use of genetic testing to identify health conditions within sub-populations that can be prevented or treated through nutritional therapy.
-
Promise
Continued research into the metabolic challenges people face across disease categories, and the guidance required to address them.
Founder
Dr. Steven Zeisel
Dr. Zeisel's research at UNC Chapel Hill established the groundwork: that choline is an essential nutrient, that individual requirements vary by several-fold, and that the variation is largely genetic. SNP Therapeutics began where that work left off, developing the models and algorithms that translate those findings into individualized nutritional guidance.
The team
Leadership
-
Jon Kleu
Chief Executive Officer
-
Al Piechotta, MBA, MEd
Chief Commercial Officer
-
Brian Smith
Chief Financial Officer
-
Steven Zeisel, MD, PhD
Chief Scientific Officer
-
Justin Pursati
Chief Technical Officer
Advisors
Clinical, scientific and commercial advisors supporting the portfolio and the research behind it.
-
Julian Abery, MSc
Lab Partner
-
John E. Allen, Jr.
Investor Relations
-
Leah Allen
Business Development
-
Jill Chisolm, MSN
Genetic Counseling Advisor
-
Bryan Chuprinko
Clinical Project Management
-
Julien Curaba, PhD
Lab Partner
-
Joshua Halpern, MD, MS
Male Reproductive Urology
-
Camille Hoffman, MD, MSc
OBGYN
-
Dan McDyer, MD
OBGYN
-
Jamie Platt, PhD
Genomics Consultant
-
Jon Thorpe, MD, MSc
OBGYN
-
Isis Trujillo-Gonzalez, PhD
Research & Development
-
Shawn Vincent
Business Development
-
Saroja Voruganti, PhD
Research & Development